Schmidt, C. Q., Harder, M. J., Nichols, E., Hebecker, M., Anliker, M., Höchsmann, B., . . . Marchbank, K. J. (2016). Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients. Immunobiology.
Chicago Stili AlıntıSchmidt, Christoph Q., et al. "Selectivity of C3-opsonin Targeted Complement Inhibitors: A Distinct Advantage in the Protection of Erythrocytes From Paroxysmal Nocturnal Hemoglobinuria Patients." Immunobiology 2016.
MLA AlıntıSchmidt, Christoph Q., et al. "Selectivity of C3-opsonin Targeted Complement Inhibitors: A Distinct Advantage in the Protection of Erythrocytes From Paroxysmal Nocturnal Hemoglobinuria Patients." Immunobiology 2016.